# Event Details - **Event Name**: Breaking the Cycle - **Event Start and End Date**: Fri, 07 Nov, 2025 at 05:30 pm – Fri, 07 Nov, 2025 at 07:30 pm - **Event Description**: Addressing Residual Inflammatory Risk in ASCVD & CKD with Next-Generation TargetedAbout this EventActivity Overview:Systemic inflammation plays a central role in the pathogenesis of atherosclerotic cardiovascular disease (ASCVD), particularly among patients with chronic kidney disease (CKD), a represents a significant contributor to residual risk among patients living with these comorbid conditions. Novel and emerging treatment options seek to target this residual risk, however their integration into clinical care are challenged by suboptimal assessment of inflammatory risk in practice. For example, while high-sensitivity C-reactive protein (hsCRP) is a valuable biomarker for quantifying residual inflammatory risk, it is significant underutilized in real-world care. In this interactive symposium, expert faculty will seamlessly integrate real-world case vignettes with cutting-edge clinical data and panel discussions to highlight evolving considerations for the role of systemic inflammation in ASCVD and CKD; underscore the potential for emerging inflammation-targeted strategies, such as IL-6 inhibition) to address residual risk; and explore practical strategies to optimize the assessment of residual inflammatory risk in practice.Target Audience:This initiative is intended for general cardiology, heart failure specialists, and preventative cardiology, physicians, advanced practice providers, and other HCPs providing cardiorenal/cardiometabolic healthcare (e.g., nephrologists, endocrinologists).Learning Objectives:· Describe the role of systemic inflammation in the development and progression of ASCVD and CKD, including the bidirectional relationship between these conditions ​· Apply evidence-based strategies to optimize the use of hsCRP in assessing residual inflammatory risk and guiding treatment decisions in ASCVD and CKD ​· Assess emerging therapeutic strategies that target residual inflammatory risk to reduce CV events in patients with ASCVD and CKD, including their mechanisms of action, efficacy, and safety ​· Evaluate the clinical implications of emerging inflammation-targeted therapies in ASCVD and CKD, including prospective considerations for clinical integration and their potential impact on patient outcomesCommercial Support:This activity is supported by an educational grant from Novo Nordisk.Disclaimer:This event is not part of the official Scientific Sessions 2025 as planned by the AHA Committee on Scientific Sessions Programming.Accreditation Info:This activity is jointly provided by AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC.Credit provided by AKH Inc., Advancing Knowledge in Healthcare.In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Catalyst Medical Education, LLC. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Ph*rm*cy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.PhysiciansAKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.For physicians, hours of participation are the number of AMA PRA Category 1 Credit(s)™ awarded.Criteria for SuccessCertificates of completion will be awarded based on the participant’s attendance and submission of the activity evaluation/claim credit form. You must participate in the entire activity to receive credit. There is no fee to participate in this activity. If you have questions about this activity, please contact AKH Inc. at tbrignoni@akhcme.com.Agenda?: 05:30 PM - 06:00 PMRegistration & DinnerIntroduction: Inflammation as a Key Driver of ASCVD & CKD RiskHost: Binita Shah, MD, MS, FSCAIOptimizing hsCRP as a Biomarker for Residual Inflammatory Risk in ASCVD & CKD Host: Paul M. Ridker, MD, MPHNovel/Emerging Therapeutic Strategies for Targeting Residual Inflammatory RiskHost: Brendan M. Everett, MD, MPHClinical Implications of Emerging Inflammation-feat. interactive casesHost: Paul M. Ridker, MD, MPHConclusions and Q&A  - **Event URL**: https://allevents.in/new-orleans/breaking-the-cycle/100001512969304919 - **Event Categories**: business, it - **Interested Audience**: - total_interested_count: 0 ## Ticket Details - **Ticket Price Range**: min: 0, max: 0, currency: USD ## Event venue details - **city**: New Orleans - **state**: LA - **country**: United States - **location**: Sheraton New Orleans Hotel, Armstrong Ballroom (8th Floor) - **lat**: 29.9518573 - **long**: -90.0679251 - **full address**: Sheraton New Orleans Hotel, Armstrong Ballroom (8th Floor), 500 Canal Street, New Orleans, United States ## Event gallery - **Alt text**: Breaking the Cycle - **Image URL**: https://cdn-az.allevents.in/events7/banners/d7eb3c999abe563405a8cca2f043e0fc5cc6e9ad41b44ba73137ceb51cec9c3d-rimg-w1200-h600-dc092b48-gmir.jpg?v=1753691591 ## FAQs - **Q**: When and where is Breaking the Cycle being held? - **A:** Breaking the Cycle takes place on Fri, 07 Nov, 2025 at 05:30 pm to Fri, 07 Nov, 2025 at 07:30 pm at Sheraton New Orleans Hotel, Armstrong Ballroom (8th Floor), 500 Canal Street, New Orleans, United States. - **Q**: Who is organizing Breaking the Cycle? - **A:** Breaking the Cycle is organized by Catalyst Medical Education, LLC. - **Q**: Who is this event for? Is it right for me? - **A:** Breaking the Cycle is ideal for curious learners, students, and skill-builders looking to gain hands-on knowledge and practical expertise in a focused, interactive setting. Whether you're a first-time attendee or a longtime enthusiast in New Orleans, this event is thoughtfully curated to deliver a standout experience worth every moment. If Breaking the Cycle sounds like your kind of event, don't wait - spots fill up fast. ## Structured Data (JSON-LD) ```json [ { "@context": "https://schema.org", "@type": "Event", "name": "Breaking the Cycle", "image": "https://cdn-az.allevents.in/events7/banners/d7eb3c999abe563405a8cca2f043e0fc5cc6e9ad41b44ba73137ceb51cec9c3d-rimg-w1200-h600-dc092b48-gmir.jpg?v=1753691591", "startDate": "2025-11-07", "endDate": "2025-11-07", "url": "https://allevents.in/new-orleans/breaking-the-cycle/100001512969304919", "location": { "@type": "Place", "name": "Sheraton New Orleans Hotel, Armstrong Ballroom (8th Floor)", "address": { "@type": "PostalAddress", "streetAddress": "500 Canal Street", "postalCode": "70130", "addressLocality": "New Orleans", "addressRegion": "LA", "addressCountry": "US" }, "geo": { "@type": "GeoCoordinates", "latitude": "29.9518573", "longitude": "-90.0679251" } }, "eventAttendanceMode": "https://schema.org/OfflineEventAttendanceMode", "description": "Addressing Residual Inflammatory Risk in ASCVD & CKD with Next-Generation Targeted", "offers": [ { "@type": "AggregateOffer", "availability": "https://schema.org/InStock", "priceCurrency": "USD", "availabilityStarts": "2026-10-12", "availabilityEnds": "2025-11-07", "validFrom": "2026-10-12", "lowPrice": "0.00", "highPrice": "0.00", "price": "0.00", "url": "https://allevents.in/new-orleans/breaking-the-cycle/100001512969304919" }, { "@type": "Offer", "availability": "https://schema.org/InStock", "priceCurrency": "USD", "availabilityStarts": "2026-10-12", "availabilityEnds": "", "validFrom": "2026-10-12", "url": "https://allevents.in/new-orleans/breaking-the-cycle/100001512969304919", "price": 0, "name": "General Admission" } ], "organizer": [ { "@type": "Organization", "name": "Catalyst Medical Education LLC", "url": "https://allevents.in/org/catalyst-medical-education-llc/20067986" } ] } ] ```